Iptacopan – November 2025

• Brand names:
  • Fabhalta®
• Pharmaceutical Company:
  • NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED
• Condition/Indication: Complement 3 glomerulopathy (C3G)
• Meeting Date: November 2025
• Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 1.3MB)
• Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 710.3KB)